Veterinary APIs Market Heats Up: Doxycycline, Florfenicol, and Tiamulin Lead Price Recovery

Veterinary APIs Price Index (VPi):
March 4th 65.95
March 11th 66.35
March 18th 67.14
March 25th 67.57

Market trading sentiment has notably intensified, propelled by widespread price hikes across major categories, resulting in an increase in market inquiries and procurement.

The veterinary APIs market is exhibiting robust performance overall, characterized by active inquiries and a favorable procurement environment. The market trend in the latter half of the month transitioned from broad-based increases to a more nuanced pattern, as the eagerness to pursue higher prices diminished. Doxycycline hydrochloride and Mequindox experienced significant upward price movements due to constrained spot supply. Neomycin sulfate, Tiamulin, and Tilmicosin have stabilized following previous declines and have seen a price recovery. Florfenicol demonstrated a distinct rebound from its lowest point, bolstered by rising costs and price support measures from manufacturers. Tylosin tartrate and Oxytetracycline have stabilized after their declines and are currently exhibiting general steadiness.

The ongoing geopolitical tensions in the Middle East are escalating, exerting pressure on the global chemical supply chain. This abrupt disruption is cascading through the industrial chain to the veterinary APIs sector. Looking forward, the differentiated market pattern is anticipated to continue. It is advisable to concentrate on core commodities that are influenced by cost transmission from the crude oil and chemical supply chains, while remaining cautious regarding commodities that lack fundamental support.

On March 25, the market price of Florfenicol stood at 169 yuan/kg, up 4.2% MoM, showing a clear rebound from the bottom. This round of price movement was primarily driven by a combination of upstream cost transmission and proactive supply-side adjustments.

Major producers frequently adopted measures such as suspending price quotations and halting order placements, fueling expectations of tightening supply. Amid geopolitical tensions in the Middle East, panic sentiment prevailed in the market, providing an opportunity for manufacturers to raise prices.

On March 25, the market price of Tiamulin stood at 250 yuan/kg, up 2.9% MoM. Although the fundamental supply-demand dynamics have not seen a decisive reversal, the downward trend has been curbed, supported by cost factors and bolstered by overall market sentiment.

Compared with the beginning of the month, the market has warmed somewhat and entered a phase of consolidating with underlying support.

On March 25, the market price of doxycycline was 352.2 yuan/kg, an increase of over 12% this month.The product had been trading at low levels previously, and manufacturers' strong intention to push prices higher was a key factor behind the recent rebound from the bottom of Doxycycline HCL.
Compounded by the ongoing escalation of the situation in the Middle East, major producers capitalized on the momentum by aggressively controlling supply through measures such as suspending price quotations and halting order placements. Driven by these dual forces, product prices have been steadily moving upward.

This month, the Tylosin Tartrate market exhibited a pattern of "declining first before stabilizing, with pressure at the bottom." The downward trend that had persisted since the fourth quarter of last year continued into early March. From the mid to late March, some major manufacturers faced tight delivery schedules.

Although market demand weakened, signs of stabilization emerged. Going forward, the market is expected to undergo a volatile upward adjustment.

For other vet APIs market information and solid inquiries, please feel free to contact us.

The vitamin market is generally on an upward trend, with intensifying price increases. Prices for VK3, VD3, and biotin have seen significant upward fluctuations. Certain manufacturers have increased their prices for vitamins C, B2, B6, and B12, while the overall market remains stable. The cost of choline chloride raw materials has risen, resulting in factory price hikes and a notable upward adjustment in market prices. Manufacturers of niacin and nicotinamide have halted quotations to fulfill prior orders, maintaining firm market prices; major producers of vitamin B1 have also suspended quotations and contracts, leading to a stable market price.

The ongoing tension has led to a continuous surge in raw material prices associated with the vitamin industry, with vitamin prices being updated on a daily basis. Concurrently, overseas manufacturers have halted supplies due to force majeure, which has incited market panic and further exacerbated the price increases in the vitamin sector.

The current vitamin market has entered a phase characterized by heightened emotions, with certain categories witnessing irrational pursuits of elevated prices. Downstream users are encouraged to exercise rationality and refrain from blindly pursuing price hikes. Historical data indicates that sharp price increases are frequently succeeded by a swift correction.

Vitamin A market prices have surged significantly, with spot prices crossing 100 yuan/kg, accumulating gains of over 85% in March alone. Recent tensions in the Middle East have served as a direct catalyst, pushing up energy prices such as crude oil and natural gas, further intensifying expectations of supply tightness. At the same time, major manufacturers have generally suspended price quotations and order placements, while traders also report being "unable to secure supply." Multiple factors have jointly driven up market prices.

Vitamin E prices have risen sharply, driven by supply expectations impacted by geopolitical conflicts and major manufacturers' intentions to control production and support prices, with spot prices approaching 100 yuan/kg. Market inquiries and procurement remain active, and the price index is running strong.

With significant upstream cost pressures, manufacturers have collectively suspended price quotations and halted order acceptance, leading to a sharp surge in prices. Current market willingness to sell is low, and the price index is running strong.

Major manufacturers of Vitamin K3 have suspended price quotations and halted order acceptance. With upstream raw material prices rising, ex-factory prices have moved upward. The market is clearly reluctant to sell, and the price index is running strong.

For market information on other vitamin products and solid inquiries, please feel free to contact us.

AMINO ACIDS MARKET
In the amino acid market, the leading manufacturers and distributors across all categories have consecutively increased their prices, influenced by the rising costs of maize and oil-related products due to the ME situation.

--Lysine : manufacturers have experienced robust export performance, prompting leading producers to halt domestic pricing while keeping export prices steady. However, downstream users are exercising caution regarding procurement at these elevated prices, resulting in a decline in inquiries and transaction activity.

--Methionine: manufacturers' prices have remained strong, with increases surpassing 150% in March alone, alongside supply control measures and a reluctance to sell. Methionine is unique among amino acid products as it is the only one extensively processed from petrochemical-based raw materials. Disruptions in transport through the Strait of Hormuz have directly led to shortages in energy and petrochemical feedstocks. Evonik has announced force majeure, and Chinese methionine manufacturers are also beginning to feel the effects, resulting in a panic-driven spike in methionine prices, despite downstream demand not likely rising correspondingly.

--Threonine: manufacturers' export prices remain stable, while major domestic producers have paused their quotations.

--Valine: manufacturers are maintaining stable quotations, with buyers adopting a buy-as-needed strategy.

--Tryptophan: manufacturers' prices are robust, spot supply is relatively constrained, and some factories have ceased their quotations.

--Arginine: activity has surged due to end-user restocking to fulfill immediate requirements, with the current market supply remaining stable.

The prices indicated in this newsletter are for your reference only and do not constitute a solid offer by our company. The transaction price shall be determined by both parties through negotiation based on the quantity and transaction conditions.

It’s a precipitated silica. It can convert aqueous and oily substances into solid substances,and play the roles of thickening, suspending, carrier and anti-caking.

It is widely used in various veterinary drugs, vitamins, flavouring agents, anti-mould agents, colouring agents, antioxidants, acidifiers, trace minerals, and other feed additive products as the carrier and anti-caking agents.

Contact us for more information

Magiacid is the trade name of feed-grade Potassium Diformate (KDF).

Potassium Diformate is a specifically conjugated acid double-salt which has been approved in the EU as a non-antibiotic growth promoter to support the growth of beneficial microflora and improve gastrointestinal balance. Experiments and field applications have proven that the product is safe, highly efficient, non-toxic and residual-free for use in farming animals.

Product page link: https://www.de-mark.com/product/detail/id/176